Zhenyu Xiao, Director, 10% Owner at DiaMedica Therapeutics Inc. (DMAC), bought 3,250 shares at $4.00 ($13K) on 2018-12-11, disclosed to the SEC on 2018-12-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.